Business Description
Attovia Therapeutics is a clinical-stage biotechnology company based in San Carlos, California, focused on developing advanced biological treatments for diseases driven by immune system dysfunction. The company's proprietary ATTOBODY platform enables the creation of therapies that target multiple disease pathways at once, offering the potential for better outcomes than existing treatments. Its current pipeline addresses a range of conditions including chronic itch disorders, inflammatory skin diseases, and inflammatory bowel disease. Founded in 2022, Attovia is building a portfolio of novel biologics designed to improve the lives of patients with serious and underserved immune-related conditions.
